Knowledge Hub

Pharmaceuticals Report On Partnerships, Licensing, Investments and M&A Deals and Trends for August 2016

Press Release   •   Oct 21, 2016 05:06 EDT

GlobalData's Partnerships, Licensing, Investments and M&A Deals and Trends for August 2016 in Pharmaceuticals report is an essential source of data and trend analysis on partnerships, licensing, mergers and acquisitions (M&As) and financings in the pharmaceuticals industry. The report provides detailed information on partnership and licensing transactions, M&As, equity/debt offerings, private equity, and venture financing registered in the pharmaceuticals industry in August 2016. The report portrays detailed comparative data on the number of deals and their value in the last six months, subdivided by deal types, various therapy areas, and geographies. Additionally, the report provides information on the top financial advisory firms in the pharmaceuticals industry.

Data presented in this report is derived from GlobalDatas proprietary in-house Pharmaceuticals eTrack deals database and primary and secondary.

Download Sample copy of this Report @

http://www.marketresearchreports.biz/sample/sample/845887

Scope

- Analysis of the market trends for the pharmaceutical industry in the global arena.

- Review of deal trends in the cardiovascular, central nervous system, dermatology, ear nose throat disorders, gastrointestinal, genito urinary system and sex hormones, hematological disorders, hormonal disorders, immunology, infectious disease, male health, metabolic disorders, mouth and dental disorders, musculoskeletal, oncology, ophthalmology, respiratory, toxicology, and women's health segments.

- Analysis of partnerships, licensing, M&As, equity/debt offerings, private equity, and venture financing deals in the pharmaceutical industry.

- Analysis of therapy areas which are very active in terms of venture capital financing, partnerships, licensing agreements, equity/debt offerings, and M&As.

- Analysis of deals based on different payment modes, including upfront and milestone payments, primarily in partnerships and licensing agreements in the pharmaceutical industry.

- Analysis of partnership and licensing deals based on clinical stage of development of products.

- Summary of the pharmaceutical deals globally in the six months.

- Information on the top deals happened in the pharmaceutical industry.

- Geographies covered include - North America, Europe, Asia Pacific, South & Central America, and the Middle East & Africa.

- League tables of financial advisors in M&As and equity/debt offerings. This includes key advisors such as Morgan Stanley, Credit Suisse, and Goldman Sachs.

Reasons to buy

- Enhance your decision making capability in a more rapid and time sensitive manner.

- Find out the major deal performing segments for investments in your industry.

- Evaluate the types of companies which are entering into partnership or licensing agreements; divesting and acquiring assets.

- Identify companies that are aggressively looking to raise capital in the market

- Evaluate niche therapy areas that are receiving majority of the upfront and milestone payments in the pharmaceutical industry.

- Identify the key venture capitalists, who are financing the pharmaceutical and biotech companies.

- Evaluate the clinical development stages where majority of the partnerships and licensing agreements are happening.

- Do deals with an understanding of how competitors are financed, and the mergers and partnerships that have shaped the pharmaceutical industry.

- Identify growth segments and opportunities in each region within the industry.

- Look for key financial advisors where you are planning to raise capital from the market or for acquisitions within the industry.

Table of Content :

1 Table of Contents

1 Table of Contents 2

1.1 List of Tables 6

1.2 List of Figures 9

2 Pharmaceuticals & Healthcare, Global, Deal Summary 12

2.1 Pharmaceuticals & Healthcare, Global, Deal Analysis, August 2016 12

2.2 Pharmaceuticals & Healthcare, Global, Major Deals, August 2016 14

2.2.1 Pfizer to Acquire Medivation in Tender Offer 14

2.2.2 Samsung Biologics Files Registration Statement for IPO for up to USD2.7 Billion 15

2.2.3 BioMarin Pharma Prices Public Offering of Shares for USD720 Million 16

2.2.4 Pfizer Acquires Bamboo Therapeutics 16

2.2.5 Sunovion Pharma to Acquire Cynapsus Therapeutics for Approximately USD624 Million 16

2.3 Pharmaceuticals & Healthcare, Global, by Type, Number of Deals, August 2016 18

2.4 Pharmaceuticals & Healthcare, Global, by Type, Deal Values, August 2016 19

3 Pharmaceuticals and Healthcare, Global, Deals, Summary, by Type 20

3.1 Pharmaceuticals & Healthcare, Global, M&A, August 2016 20

3.1.1 Top M&A Deals in August 2016 21

3.1.2 Pharmaceuticals & Healthcare, Global, M&A Deals by Therapy Area, March 2016 - August 2016 22

3.2 Pharmaceuticals & Healthcare, Global, Equity Offering Deals, August 2016 23

3.2.1 Top Equity Offering Deals in August 2016 24

3.2.2 Pharmaceuticals & Healthcare, Global, Equity Offering Deals by Therapy Area, March 2016 - August 2016 25

3.3 Pharmaceuticals & Healthcare, Global, Private Equity and Venture Capital Deals, August 2016 26

3.3.1 Top PE/VC Deals in August 2016 27

3.3.2 Pharmaceuticals & Healthcare, Global, PE/VC by Therapy Area, August 2016 28

3.3.3 Pharmaceuticals & Healthcare, Global, Venture Capital Deals by Stage of Financing, August 2016 29

3.3.4 Pharmaceuticals & Healthcare, Global, Top Venture Financing Firms, March 2016-August 2016 31

3.3.5 Pharmaceuticals & Healthcare, Global, Top VC Backed Companies, March 2016-August 2016 32

3.4 Pharmaceuticals & Healthcare, Global, Partnership Deals, August 2016 33

3.5 Pharmaceuticals & Healthcare, Global, Partnership Deals by Therapy Area, March 2016 - August 2016 35

3.6 Pharmaceuticals & Healthcare, Global, Partnership Deals by Upfront and Milestone Payments and Deal Values (US$ m), August 2016 36

3.6.1 Pharmaceuticals & Healthcare, Global, Top Partnership Deals by Payment Mode, August 2016 37

3.7 Pharmaceuticals & Healthcare, Global, Partnership Deals by Therapy Area, by Upfront and Milestone Payments and Deal Values (US$ m), March 2016 - August 2016 38

3.8 Pharmaceuticals & Healthcare, Global, Partnership Deals by Phase, Number Of Deals, March 2016 - August 2016 40

3.9 Pharmaceuticals & Healthcare, Global, Partnership Deals by Phase, Deal Values (US$ m), March 2016 - August 2016 41

3.10 Pharmaceuticals & Healthcare, Global, Partnership Deals by Phase, by Upfront & Milestone Payments and Deal Values (US$ m), March 2016 - August 2016 43

4 Pharmaceuticals & Healthcare, Global, Licensing Agreements, August 2016 45

4.1 Pharmaceuticals & Healthcare, Global, Licensing Agreements, August 2016 45

4.2 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals, Upfront and Milestone Payments and Deal Values (US$ m), August 2016 47

4.3 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals by Therapy Area, Total Deal Values (US$ m), March 2016 - August 2016 49

4.4 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals by Therapy Area, Upfront Payments and Milestone Payments (US$ m), March 2016 - August 2016 51

4.5 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals by Phase, Total Deal Values (US$ m), March 2016 - August 2016 52

MarketResearchReports.biz is the most comprehensive collection of market research reports. MarketResearchReports.Biz services are specially designed to save time and money for our clients. We are a one stop solution for all your research needs, our main offerings are syndicated research reports, custom research, subscription access and consulting services. We serve all sizes and types of companies spanning across various industrie